Pure Extracts (PULL) is a company that uses CO2 extraction technology to derive full spectrum oil from cannabis biomass. Their purest quality and purity makes them an emerging leader…
Psychedelics
The NYSE Cybin (CYBN.N) just finished its first trading day on the New York Stock Exchange (NYSE) after announcing the upcoming uplisting last month. It was a less…
Filament Health (FH.NE) received the first ever psilocybin (and other associated psychoactive compounds) extraction and standardization patent for a public company by the Canadian Intellectual Property Office today, according…
Mindset Pharma (MSET.C) announced that they have filed an international patent for their novel psilocybin synthesis method. The application covers Mindset’s Synthesis Process, a process they call “ground-breaking” and…
Cybin (CYBN.NE) announced today that it has closed its previously announced overnight marketed offering including the exercise in full of the over-allotment option granted to the Underwriters. “Investor demand…
Mushroom enthusiasts Filament Health (FH.NE) is looking at mushroom compounds far beyond just psilocybin as the company is run by actual mushroom enthusiasts with access to a lot of…
Red Light Holland (TRIP.C) announced they have entered into a definitive agreement as part of their acquisition of Mera Life Sciences. Red Light and Mera have entered into an…
Braxia Scientific (BRAX.C) filed their Q4 and full year-end results for the three and twelve month periods ending on March 31, 2021. At the end of March 2021, Braxia…
Cybin (CYBN.NE) announced that they have received final approval from the New York Stock Exchange (NYSE) to list its shares on the NYSE American exchange. Beginning next Thursday, on…
Filament Health (FH.NEO) announced today that it has been granted an amendment to its existing Health Canada Dealer’s License, bolstering the Company’s position at the forefront of natural psychedelic…